GlassScriptPhysician profile
Cheyenne Manafi
NPI 1447996251
$1,132.54
in general payments reported to CMS, 2019-2025
14 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $81.50 · 2023: $156 · 2024: $259 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $234.41 | 2022-2024 | Sonicpin, Variax |
| Treace Medical Concepts, INC. | $149.99 | 2025 | |
| Depuy Synthes Sales INC. | $143.62 | 2025 | Minibunion, Vivigen Mis Delivery System, Motoband |
| Smith+Nephew, INC. | $141.80 | 2025 | Collagenase Santyl |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2024 | Exparel |
| Ani Pharmaceuticals, INC. | $105.74 | 2025 | Purified Cortrophin Gel |
| Kci USA, INC. | $64.88 | 2022 | |
| Organogenesis INC. | $37.71 | 2024 | Apligraf |
| Solventum Corporation | $34.28 | 2025 | Activ.A.C. |
| Vertex Pharmaceuticals Incorporated | $28.12 | 2025 | |
| Janssen Pharmaceuticals, INC | $21.18 | 2024 | Xarelto |
| Lifenet Health | $18.59 | 2025 | Theragenesis Wound Matrix |
| Paratek Pharmaceuticals, INC. | $13.81 | 2025 | Nuzyra |
| Eclipse Technology Solutions INC. | $13.41 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheyenne Manafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.